REGENXBIO Inc. (RGNX) Shareholders’ equity 2016–2025
REGENXBIO Inc. (RGNX) shareholders’ equity at each fiscal year-end, per SEC filings.
$102.7MFY2025 · since FY2016: $161.7M → $102.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $102.7M | -60.4% |
| FY2024 | $259.7M | -16.7% |
| FY2023 | $311.7M | -39.6% |
| FY2022 | $516.2M | -32.5% |
| FY2021 | $764.3M | +102.3% |
| FY2020 | $377.8M | -16.1% |
| FY2019 | $450.2M | -11.5% |
| FY2018 | $508.8M | +178.0% |
| FY2017 | $183.0M | +13.2% |
| FY2016 | $161.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice